• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Prelude Therapeutics Incorporated - Common Stock (NQ:PRLD)

    5.350 +0.910 (+20.50%)
    Streaming Delayed Price Updated: 9:34 AM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Prelude Therapeutics Incorporated - Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Stocks That Hit 52-Week Lows On Friday ↗
      Friday's session saw 59 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
      During Thursday, 56 stocks hit new 52-week lows. 
    Via Benzinga
    Expert Ratings for Prelude Therapeutics ↗
     
    Via Benzinga
    Analyst Ratings for Prelude Therapeutics ↗
     
    Via Benzinga
    News headline image
    Prelude Therapeutics To Participate in Jefferies Healthcare Conference
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Prelude Therapeutics Announces Pricing of Public Offering
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics Announces Launch of Proposed Public Offering
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
    Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline 
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    The 7 Worst Stocks to Buy Now ↗
    With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now. 
    Via InvestorPlace
    News headline image
    Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Carvana, Crocs And Other Big Losers From Monday ↗
    U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    News headline image
    Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. 
    Via Benzinga
    News headline image
    Why This Prelude Therapeutics Analyst Disagrees With 2 Others And Downgraded The Stock ↗
    Shares of Prelude Therapeutics Inc (NASDAQ: PRLD) came under pressure during early trading on Monday. 
    Via Benzinga
    News headline image
    Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday ↗
    U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    News headline image
    Prelude Therapeutics Receives FDA Clearance of IND for PRT3789, a Potent and Selective First-in-Class SMARCA2 Protein Degrader
    Phase 1 Study Will Include Biomarker Selected Patients with Advanced Solid Tumors 
    From Prelude Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗
      
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
    On Thursday, 236 companies hit new 52-week lows. 
    Via Benzinga
    News headline image
    68 Biggest Movers From Yesterday ↗
    Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie... 
    Via Benzinga
    News headline image
    38 Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗
    Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.